BartelsFNobisKCooperGet al. Childhood multiple sclerosis is associated with reduced brain volumes at first clinical presentation and brain growth failure. Mult Scler2019; 25(7): 927–936.
2.
ThompsonABanwellBBarkhofFet al. Diagnosis of multiple sclerosis: 2017 revisions of the “McDonald” criteria. Lancet Neurol2018; 17: 162–173.
3.
KurtzkeJF.Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology1983; 33(11): 1444–1452.
4.
KerbratAAubert-BrocheBFonovVet al. Reduced head and brain size for age and disproportionately smaller thalami in child-onset MS. Neurology2012; 78(3): 194–201.
5.
Aubert-BrocheBFonovVNarayananSet al. Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth. Neurology2014; 83(23): 2140–2146.
6.
WeierKFonovVAubert-BrocheBet al. Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease. Mult Scler2016; 22(10): 1266–1278.
7.
ChitnisTArnoldDLBanwellBet al. Trial of fingolimod versus interferon beta-1a in pediatric multiple sclerosis. N Engl J Med2018; 379(11): 1017–1027.
MarrieRACohenJStuveOet al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler2015; 21(3): 263–281.
10.
BrownRANarayananSBanwellBet al. Magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients. Neuroimage Clin2014; 6: 237–242.
11.
GormanMPHealyBCPolgar-TurcsanyiMet al. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol2009; 66(1): 54–59.
12.
GhassemiRAntelSBNarayananSet al. Lesion distribution in children with clinically isolated syndromes. Ann Neurol2008; 63(3): 401–405.
13.
VerheyLHSignoriAArnoldDLet al. Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials. Neurology2013; 81(14): 1215–1221.
